Journal
PANCREATOLOGY
Volume 19, Issue 2, Pages 266-273Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.pan.2019.01.012
Keywords
Acute pancreatitis; Menadione; Hydrogen sulphide; Preprotachykinin-A; Neurokinin-1 receptor
Categories
Funding
- Vellore Institute of Technology, Vellore, Tamil Nadu, India
Ask authors/readers for more resources
Objective: We aim to study the protective effect of menadione on caerulein-induced acute pancreatitis (AP) and associated lung injury and to explore the possible mechanism. Methods: Male Swiss mice randomized into control and different experimental groups. AP was induced in mice by six hourly intraperitoneal (i.p) injections of caerulein (50 mg/kg at 1 h interval). Menadione (10 mg/kg) was administered one hour (i.p, 10 mg/kg) after the first caerulein injection and control animals were given hourly intraperitoneal (i.p) injection of isotonic sodium chloride solution for 6 hours. Results: Administration of menadione attenuated the severity of AP and associated lung injury as shown by the histopathology, reduced MPO and serum amylase activity. Further, the anti-inflammatory effect of menadione was associated with a reduction of pancreatic and pulmonary proinflammatory cytokine interleukin 1 beta (IL-1 beta) and hydrogen sulfide (H2S). Moreover, menadione inhibited caerulein-induced cystathionine-gamma-lyase, preprotachykinin-A (PPTA) and neurokinin-1 receptor (NK-1R) expression in pancreas and lungs. Also menadione further enhances the beneficial effect by reducing caerulein-induced nuclear factor (NF) -kappa B activation in both pancreas and lung. Conclusion: The present findings show for the first time that in AP, menadione may exhibit an anti-inflammatory effect by down-regulating substance-P and H2S signaling via the NF-kappa B pathway. (C) 2019 IAP and EPC. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available